JP2024528097A5 - - Google Patents
Info
- Publication number
- JP2024528097A5 JP2024528097A5 JP2024505421A JP2024505421A JP2024528097A5 JP 2024528097 A5 JP2024528097 A5 JP 2024528097A5 JP 2024505421 A JP2024505421 A JP 2024505421A JP 2024505421 A JP2024505421 A JP 2024505421A JP 2024528097 A5 JP2024528097 A5 JP 2024528097A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- xylitol
- glycerol
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21189429 | 2021-08-03 | ||
| EP21189429.0 | 2021-08-03 | ||
| PCT/EP2022/071842 WO2023012224A1 (en) | 2021-08-03 | 2022-08-03 | Peptidase formulation for treatment of microbial infections in the upper respiratory tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528097A JP2024528097A (ja) | 2024-07-26 |
| JP2024528097A5 true JP2024528097A5 (enExample) | 2025-08-07 |
Family
ID=77207007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505421A Pending JP2024528097A (ja) | 2021-08-03 | 2022-08-03 | 上気道における微生物感染の治療のためのペプチダーゼ製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240173387A1 (enExample) |
| EP (1) | EP4380549B1 (enExample) |
| JP (1) | JP2024528097A (enExample) |
| CN (1) | CN117794513A (enExample) |
| WO (1) | WO2023012224A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6599883B1 (en) * | 1998-10-30 | 2003-07-29 | Nastech Pharmaceutical Company, Inc. | Nasal delivery of xylitol |
| CN100584376C (zh) * | 2006-05-25 | 2010-01-27 | 广西亚热带作物研究所 | 治疗深度带痂糜烂性创伤的药物 |
| EP3121272A1 (en) * | 2015-07-24 | 2017-01-25 | Zymetech ehf. | Novel fish trypsin isoforms and their use |
| GB201800274D0 (en) * | 2018-01-08 | 2018-02-21 | Enzymatica Ab | Novel treatments |
| US11013687B1 (en) * | 2020-06-08 | 2021-05-25 | Amcyte Pharma, Inc. | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 |
-
2022
- 2022-08-03 CN CN202280054111.3A patent/CN117794513A/zh active Pending
- 2022-08-03 US US18/577,585 patent/US20240173387A1/en active Pending
- 2022-08-03 WO PCT/EP2022/071842 patent/WO2023012224A1/en not_active Ceased
- 2022-08-03 EP EP22760745.4A patent/EP4380549B1/en active Active
- 2022-08-03 JP JP2024505421A patent/JP2024528097A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505046A5 (enExample) | ||
| RU2011137961A (ru) | Фармацевтические составы и способы лечения инфекций дыхательных путей | |
| JP2006516648A5 (enExample) | ||
| CN1270689C (zh) | 固体口腔用抗牙垢和抗牙菌斑组合物 | |
| JP2004525928A5 (enExample) | ||
| JP2018523635A5 (enExample) | ||
| JP2007145876A5 (enExample) | ||
| JP2001199882A (ja) | 感冒・鼻炎用組成物 | |
| JP2022537178A5 (enExample) | ||
| JP2022504181A5 (enExample) | ||
| JP2024528097A5 (enExample) | ||
| EP1841439B1 (en) | Compositions comprising extracts from sanguinaria or macleaya, vaccinium myrtillus or vitis vinifera and echinacea angustifolia | |
| JP2002332229A (ja) | 感冒用組成物 | |
| JP6975473B2 (ja) | 鼻詰まりを治療／予防するためのカルボン酸 | |
| JP2023532170A5 (enExample) | ||
| Treanor | Respiratory infections | |
| JP2000080036A (ja) | 新規な治療方法 | |
| JP2002348240A (ja) | 医薬組成物 | |
| JP2023518376A5 (enExample) | ||
| JP2023524064A5 (enExample) | ||
| JPH09175968A (ja) | 口腔用組成物 | |
| TW200404550A (en) | Cepharospolin formulation for oral use | |
| JPS6326082B2 (enExample) | ||
| JPH0513129B2 (enExample) | ||
| EP2320870B1 (en) | Topical intranasal composition usable in the case of nasal obstruction |